Latest Breaking News On - கெவின் முள் - Page 8 : comparemela.com

Hologic to Acquire Biotheranostics, Leader in Molecular Tests for Breast and Metastatic Cancers Transaction accelerates Hologic’s entry into oncology growth market, provides new lab capabilities Getty Images January 6, 2021   Hologic, Inc., a global leader in women s health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing adjustments. “Acquiring Biotheranostics enables us to jump-start our entry into a large, fast-growing oncology adjacency that fits perfectly with our broader corporate focus and passion for women’s health,” said Kevin Thornal, Hologic’s Division President, Diagnostics. “Together with the Biotheranostics team, we can leverage our commercial capabilities and expertise in molecular diagnostics automation to accelerate growth, he

United statesDon hardisonKevin thornalSteve macmillanClinical laboratory improvement amendmentsHologic divisionBiotheranostics incHologic incDivision presidentChief executiveBreast cancer indexஒன்றுபட்டது மாநிலங்களில்தாதா கடினத்தன்மைகெவின் முள்ஸ்டீவ் மேக்மில்லன்மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள்